Heart & Lung: The Journal of Acute and Critical Care
Volume 39, Issue 3 , Pages 237-239 , May 2010

Successful treatment of saphenous venous graft thrombus by tirofiban infusion

References 

  1. Grines CL, Booth DC, Nissen SE, et al. Mechanism of acute myocardial infarction in patients with prior coronary artery bypass grafting and therapeutic implications. Am J Cardiol. 1990;65:1292–1296
  2. Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Circulation. 1985;71:699–708
  3. Hasdai D, Garrat KN, Holmes DR, Berger PB, Schwartz RS, Bell MR. Coronary angioplasty and intracoronary thrombolysis are of limited efficacy in resolving early intracoronary stent thrombosis. J Am Coll Cardiol. 1996;28:361–367
  4. Abbo KM, Dooris M, Glazier S, et al. Features and outcome of no-reflow after percutaneous coronary intervention. Am J Cardiol. 1995;75:778–782
  5. Carrozza JP, Mumma M, Breall JA, Fernandez A, Heyman E, Metzger C. Randomized evaluation of the TriActiv balloon protection flush and extraction system for the treatment of saphenous vein graft disease. J Am Coll Cardiol. 2005;46:1677–1683
  6. Lim MJ, Young JJ, Senter SR, Klein LW. Determinants of embolic protection device use: case study in the acceptance of a new medical technology. Catheter Cardiovasc Intervent. 2005;65:597–599
  7. Mathew V, Grill DE, Scott CG, et al. The influence of abciximab use on clinical outcome after aortocoronary vein graft interventions. J Am Coll Cardiol. 1999;34:1163–1169
  8. Roffi M, Mukherjee D, Chew DP, et al. Lack of benefit from intravenous platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment for percutaneous interventions of aortocoronary bypass grafts: a pooled analysis of five randomized clinical trials. Circulation. 2002;106:3063–3067
  9. Kalyanasundaram A, Blankenship JC, Berger P, Herrmann H, McClure R, Moliterno D. Thrombus predicts ischemic complications during percutaneous coronary intervention in saphenous vein grafts: results from TARGET (Do Tirofiban and ReoPro Give Similar Efficacy? Trial). Catheter Cardiovasc Intervent. 2007;69:623–629
  10. Limbruno U, Micheli A, De Carlo M, et al. Mechanical prevention of distal embolization during primary angioplasty: safety, feasibility, and impact on myocardial reperfusion. Circulation. 2003;108:171–176
  11. Sabatine MS, Jang IK. The use of glycoprotein IIb/IIIa inhibitors in patients with coronary artery disease. Am J Med. 2000;109:224–237
  12. Dagdelen S, Soydinc S, Ergelen M, Caglar N. Resolution of a spontaneous coronary artery thrombus with a new antiplatelet agent. Int Angiol. 2001;20:244–247
  13. Ozeren A, Aydin M, Ozkökeli M, Unalacak M, Bilge M. Treatment of intracoronary thrombus using tirofiban in a patient with normal coronary arteries. Jpn Heart J. 2004;45:343–346
  14. DeWood MA, Spores J, Notske R, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med. 1980;303:897–902
  15. Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation. 1998;97:916–931
  16. Ozkan M, Sag C, Yokusoglu M, et al. The effect of tirofiban and clopidogrel pretreatment on outcome of old saphenous vein graft stenting in patients with acute coronary syndromes. Tohoku J Exp Med. 2005;206:7–13
  17. Hartmann JR, McKeever LS, Stamato NJ, et al. Recanalization of chronically occluded aortocoronary saphenous vein bypass grafts by extended infusion of urokinase: initial results and short-term clinical follow-up. J Am Coll Cardiol. 1991;18:1517–1523
  18. Robinson N, Barakat K, Dymond D. Platelet IIb/IIIa antagonists followed by delayed stent implantation. A new treatment for vein graft lesions containing massive thrombus. Heart. 1999;81:434–437
  19. Gruberg L, Amikam S. Prolonged systemic delivery of tirofiban in a thrombus-laden saphenous vein graft. Int J Cardiovasc Intervent. 2003;5:92–94

PII: S0147-9563(09)00183-6

doi: 10.1016/j.hrtlng.2009.07.001

Heart & Lung: The Journal of Acute and Critical Care
Volume 39, Issue 3 , Pages 237-239 , May 2010